RE:RE:Pfizer or Roche as jv partners for the NMIBC In a complete buyout, Merck has much more incentive. They could start by moving on many new indications to keep them as the lead in cancer treatment. At the same time they could slowly promote the use of TLD 1433 so there would no longer be a need for the new plant to produce more BCG . That plant could be use to make the vaccine to rid the world of Covid. This would be a major boost to a market they have not been in.
Which ever of the three that take out Theralase, they have many ways to expand it to be a major player.